Jack Schlossberg, a 33-year-old grandson of President John F. Kennedy, is rolling out a national policy proposal aimed at removing financial barriers to HIV prevention. As a Democratic candidate in the closely watched race for New York’s 12th District seat, he is positioning the initiative not only as public health policy but as a political rebuke of his cousin, HHS Secretary Robert F. Kennedy Jr., whom he accuses of dismantling federal prevention efforts. Schlossberg’s campaign calls the initiative the No Pay PrEP & PEP Plan, and the primary contest includes names such as Micah Lasher, Alex Bores, and George Conway; the Democratic primary is scheduled for June 23.
At the heart of Schlossberg’s announcement are two complementary reforms designed to guarantee access to medication that prevents HIV transmission. The first component would require both public and private insurers to cover all FDA-approved PrEP options and PEP without any out-of-pocket expenses, while a parallel federal voucher program would assist uninsured and underinsured people. The second component creates a permanent financing mechanism, described by the campaign as an HIV Prevention Trust Fund, intended to shield prevention programs from annual budget battles and abrupt cuts in resources.
Policy mechanisms and enforcement
Schlossberg’s prescription for broad coverage prioritizes practical, enforceable rules: no copays, no deductibles, no prior authorization hurdles and explicit inclusion of every FDA-cleared prevention drug. The plan emphasizes that technical terms like zero cost-sharing should be treated as standard contract language, not optional promises. For those outside the insurance system, his proposal would allocate vouchers to cover medication and associated clinical visits, aiming to close coverage gaps caused by exclusions, formulary limits, or narrow interpretations of benefits that currently leave some patients paying at the pharmacy.
Coverage enforcement and vouchers
Under the initiative, compliance would be monitored through federal oversight and reporting requirements so insurers cannot exploit loopholes to impose hidden charges. The voucher component is meant to function as a safety net: individuals without consistent insurance could access PrEP and PEP through federally funded certificates redeemable at participating providers and pharmacies. By combining mandatory insurer coverage with targeted vouchers, the plan intends to make prevention reliably accessible at the point of care for everyone who needs it.
A permanent funding stream
The proposed HIV Prevention Trust Fund aims to convert episodic line-item appropriations into a stable revenue source dedicated to prevention programs, outreach, testing, surveillance and linkage to care. Schlossberg argues that prevention is infrastructure: patchwork annual funding creates uncertainty and fragility. A trust fund would protect long-term initiatives from political swings and administrative reshuffles, ensuring that public health systems—rather than short-term budget priorities—sustain the services that keep infections down.
Public health context and recent advances
Schlossberg frames his proposal against the backdrop of recent federal efforts to expand targeted HIV and STI prevention. Under the previous administration, officials rolled out guidance for doxyPEP prescribing to reduce syphilis and other infections among gay, bisexual men and transgender women; research from the University of Washington linked broader doxyPEP use to notable declines in syphilis in affected communities. Public health leaders, including former CDC and HHS officials, have cited these steps as examples of data-driven interventions focused on populations most impacted by STIs.
Budget cuts, reorganization and critique
The announcement also responds to sweeping changes at the Department of Health and Human Services under Secretary Robert F. Kennedy Jr., which Schlossberg and public health advocates say threaten prevention infrastructure. Budget proposals cited in public documents would reduce NIH HIV and AIDS research funding from roughly $3.29 billion to about $1.91 billion, while independent analyses suggest reorganization and new priorities could produce more than $1.5 billion in cuts across programs that prevent and respond to HIV. The administration has proposed consolidating functions into an entity called the Administration for a Healthy America, a move critics argue would disrupt testing, surveillance, outreach and linkage-to-care systems crucial to avoiding new infections. HHS spokespeople have defended the changes as prioritization, but public health leaders and advocates warn the shifts risk eroding services targeted at LGBTQ+ communities.
Political confrontation and personal motivation
For Schlossberg the issue blends policy and personal conviction. He sharply criticizes both President Trump’s administration and his cousin’s role within it, portraying recent decisions as an attack on vulnerable communities and a rollback of hard-won progress. He has been publicly vocal since his cousin joined the administration and frames the plan as a direct electoral response. Schlossberg traces his engagement with HIV advocacy to formative academic experiences and cites public figures who raised the issue nationally; he says the fight to protect prevention funding is both a political mission and a promise to those who rely on uninterrupted access to lifesaving medications.